CM/TNS/24/5713 - NHS Framework for Transition products - 1 February 2025
NHS England
Published on NHS Health Family Atamis procurement portal
This tender has closed
The submission deadline for this contract has passed. There may be more active goods tenders from NHS England, and hundreds more across the UK public sector.
Key details
Procurement
- 33600000 Pharmaceutical products
What happened
NHS England awarded this contract to Sun Pharma UK Ltd | Thornton and Ross Ltd | Dr.Reddy's Laboratories (UK) Limited | Zentiva Pharma UK Ltd | Biocon | Baxter Healthcare Ltd worth £9,867,000 on 14 Jan 2025. The contract runs until 31 May 2026.
Description
Project title: NHS National Framework for Transition products commencing 1 February 2025 Offer reference number: CM/TNS/24/5713 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement:
CM/TNS/24/5713/01 - Eribulin Injection, Bosutinib Tablets and Liraglutide Injection
Lot 1 CESW: 01/02/2025 to 31/05/2026 (16 months) Lot 2 LSNE: 01/02/2025 to 31/05/2026 (16 months) Lot 3 NWLN: 01/02/2025 to 31/05/2026 (16 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Awarded suppliers (6)
- Sun Pharma UK Ltd
- Thornton and Ross Ltd
- Dr.Reddy's Laboratories (UK) Limited
- Zentiva Pharma UK Ltd
- Biocon
- Baxter Healthcare Ltd
Contact
Identifiers
Explore related tenders
Other tenders from NHS England
View all →External ID: cf-ocds-b5fd17-e85a5f73-1208-4e45-a159-08011aef8a18 • Added 3 October 2026